Literature DB >> 17640814

Late toxicity in survivors from adolescent cancers.

George Pentheroudakis1, Nicholas Pavlidis.   

Abstract

Nowadays three quarters of adolescents with cancer are cured but half of them experience a late toxic effect of antineoplastic therapy that interferes with their physical and psychosocial health. This review recapitulates late effects associated with radiation therapy, chemotherapy and surgery, reviews risk factors and prognosis and suggests follow-up and management strategies, excluding fertility issues. Adolescents with cancer should be the focus of active clinical research for the optimisation of antineoplastic treatment as well as for breakthroughs in the follow-up, prevention and management of toxic effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640814     DOI: 10.1016/j.ctrv.2007.06.002

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  2 in total

1.  High-risk clinical stage I NSGCT: the case for RPLND.

Authors:  Christopher Morash; Ilias Cagiannos
Journal:  World J Urol       Date:  2009-06-02       Impact factor: 4.226

2.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.